These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28746904)

  • 41. A systematic review of St. John's wort for major depressive disorder.
    Apaydin EA; Maher AR; Shanman R; Booth MS; Miles JN; Sorbero ME; Hempel S
    Syst Rev; 2016 Sep; 5(1):148. PubMed ID: 27589952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis.
    Zhou X; Cipriani A; Furukawa TA; Cuijpers P; Zhang Y; Hetrick SE; Pu J; Yuan S; Del Giovane C; Xie P
    BMJ Open; 2018 Jan; 8(1):e018357. PubMed ID: 29306886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidepressant treatment for postnatal depression.
    Molyneaux E; Howard LM; McGeown HR; Karia AM; Trevillion K
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002018. PubMed ID: 25211400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for depression and anxiety among patients with acute coronary syndrome in acute care settings: a scoping review.
    Marin TS; Walsh S; May N; Jones M; Gray R; Muir-Cochrane E; Clark RA
    JBI Evid Synth; 2020 Sep; 18(9):1932-1969. PubMed ID: 32813429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment-resistant depression and mortality after acute coronary syndrome.
    Carney RM; Freedland KE
    Am J Psychiatry; 2009 Apr; 166(4):410-7. PubMed ID: 19289455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for depression among the general adult population and in women during pregnancy or the first-year postpartum: two systematic reviews to inform a guideline of the Canadian Task Force on Preventive Health Care.
    Beck A; Hamel C; Thuku M; Esmaeilisaraji L; Bennett A; Shaver N; Skidmore B; Colman I; Grigoriadis S; Nicholls SG; Potter BK; Ritchie K; Vasa P; Shea BJ; Moher D; Little J; Stevens A
    Syst Rev; 2022 Aug; 11(1):176. PubMed ID: 35996176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
    McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of an adjuvant antidepressant on the efficacy of electroconvulsive therapy: A systematic review and meta-analysis.
    Pluijms EM; Kamperman AM; Hoogendijk WJ; Birkenhäger TK; van den Broek WW
    Aust N Z J Psychiatry; 2021 Apr; 55(4):366-380. PubMed ID: 32900217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.
    Udina M; Hidalgo D; Navinés R; Forns X; Solà R; Farré M; Capuron L; Vieta E; Martín-Santos R
    J Clin Psychiatry; 2014 Oct; 75(10):e1113-21. PubMed ID: 25373120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Milnacipran versus other antidepressive agents for depression.
    Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006529. PubMed ID: 19588396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Balk F; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004044. PubMed ID: 16235348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidepressant prophylaxis reduces depression risk but does not improve sustained virological response in hepatitis C interferon recipients without depression at baseline: a systematic review and meta-analysis.
    Al-Omari A; Cowan J; Turner L; Cooper C
    Can J Gastroenterol; 2013 Oct; 27(10):575-81. PubMed ID: 24106729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.
    Cox GR; Fisher CA; De Silva S; Phelan M; Akinwale OP; Simmons MB; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD007504. PubMed ID: 23152246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
    Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA;
    CNS Drugs; 2008; 22(7):587-602. PubMed ID: 18547127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interventions to improve return to work in depressed people.
    Nieuwenhuijsen K; Faber B; Verbeek JH; Neumeyer-Gromen A; Hees HL; Verhoeven AC; van der Feltz-Cornelis CM; Bültmann U
    Cochrane Database Syst Rev; 2014 Dec; (12):CD006237. PubMed ID: 25470301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.